Adeno-Associated Virus Variant Patent Application
Summary
The USPTO published patent application US20260109956A1 on April 23, 2026, disclosing an adeno-associated virus 2 (AAV2) variant invented by Dong Woo Song and Hyekyung Oh. The application claims VP1 variants comprising amino acid sequences selected from SEQ ID NOS: 02 to 31. Filing date was October 28, 2025, under application number 19371743. The patent application is classified under CPC codes C12N 7/00 and C07K 14/005, placing it within the biotechnology and gene therapy vector arts.
“An AAV variant according to some embodiments of the present disclosure comprises a VP1 variant comprising having any one amino acid sequence selected from SEQ ID NOS: 02 to 31.”
About this source
GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 264 changes logged to date.
What changed
The USPTO published patent application US20260109956A1 disclosing an AAV2 variant comprising VP1 variants with amino acid sequences selected from SEQ ID NOS: 02 to 31. The application was filed on October 28, 2025, and published on April 23, 2026.
For biotechnology companies developing gene therapy products using AAV vectors, this patent application represents prior art that may affect freedom-to-operate analyses. Companies working with AAV2-related technologies should monitor the prosecution of this application to assess potential licensing requirements or design-around strategies.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ADENO-ASSOCIATED VIRUS VARIANT
Application US20260109956A1 Kind: A1 Apr 23, 2026
Inventors
Dong Woo SONG, Hyekyung OH
Abstract
The present disclosure relates to an AAV variant, for example, an AAV2 variant. An AAV variant according to some embodiments of the present disclosure comprises a VP1 variant comprising having any one amino acid sequence selected from SEQ ID NOS: 02 to 31.
CPC Classifications
C12N 7/00 C07K 14/005 C12N 2750/14121 C12N 2750/14122
Filing Date
2025-10-28
Application No.
19371743
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.